27721600|t|Sonic hedgehog in oral squamous cell carcinoma: An immunohistochemical study
27721600|a|Recent studies have revealed the involvement of hedgehog (Hh) signaling component in proliferation and invasive behavior of many carcinomas. This study aims to identify the expression of sonic Hh (SHH) protein of SHH pathway in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC) using SHH (H-160) (Santa Cruz, sc-9042) which could have therapeutic implication in future. A total of 250 cases comprising 50 normal oral mucosa, 50 cases of oral epithelial dysplasia, 50 well, 50 moderate and 50 poorly differentiated OSCCs were included in the study. Immunohistochemical evaluation of SHH protein expression was conducted using monoclonal antibody. Interpretation of the expression was done by immunoreactive score of Remmele and Stegner (IRS) scoring method. Chi-Square test was used to analyze the results. The study showed that SHH signaling molecules are highly expressed in OSCC, and their expression was mainly in the cytoplasm of epithelial cells. The SHH signaling component is associated with the pathological parameter in OSCC and oral epithelial dysplasia.
27721600	0	14	Sonic hedgehog	T116,T123	C1457880
27721600	18	46	oral squamous cell carcinoma	UnknownType	C0747035
27721600	51	70	immunohistochemical	T059	C1441616
27721600	71	76	study	T062	C2603343
27721600	84	91	studies	T062	C2603343
27721600	97	105	revealed	T080	C0443289
27721600	125	148	hedgehog (Hh) signaling	T044	C1155468
27721600	149	158	component	T116,T123	C1179435
27721600	162	175	proliferation	T169	C1514485
27721600	180	197	invasive behavior	T080	C0205281
27721600	206	216	carcinomas	T191	C0007097
27721600	223	228	study	T062	C2603343
27721600	250	260	expression	T045	C1171362
27721600	264	286	sonic Hh (SHH) protein	T116,T123	C1457880
27721600	290	301	SHH pathway	T044	C1519425
27721600	305	309	oral	T030	C0226896
27721600	310	330	epithelial dysplasia	T191	C0878500
27721600	335	363	oral squamous cell carcinoma	UnknownType	C0747035
27721600	365	369	OSCC	UnknownType	C0747035
27721600	377	380	SHH	T116,T123	C1457880
27721600	382	387	H-160	T116,T123	C1457880
27721600	428	451	therapeutic implication	T061	C0087111
27721600	505	509	oral	T030	C0226896
27721600	510	516	mucosa	T024	C0026724
27721600	530	534	oral	T030	C0226896
27721600	535	555	epithelial dysplasia	T191	C0878500
27721600	569	577	moderate	T080	C0205081
27721600	585	606	poorly differentiated	T080	C0205617
27721600	607	612	OSCCs	UnknownType	C0747035
27721600	634	639	study	T062	C2603343
27721600	641	660	Immunohistochemical	T059	C1441616
27721600	661	671	evaluation	T058	C0220825
27721600	675	686	SHH protein	T116,T123	C1457880
27721600	687	697	expression	T045	C1171362
27721600	718	737	monoclonal antibody	T116,T129	C0003250
27721600	739	753	Interpretation	T170	C0459471
27721600	761	771	expression	T045	C1171362
27721600	784	848	immunoreactive score of Remmele and Stegner (IRS) scoring method	T062	C0036449
27721600	850	865	Chi-Square test	T170	C0008041
27721600	878	885	analyze	T062	C0936012
27721600	890	897	results	T169	C1274040
27721600	903	908	study	T062	C2603343
27721600	921	934	SHH signaling	T044	C3158055
27721600	956	965	expressed	T045	C1171362
27721600	969	973	OSCC	UnknownType	C0747035
27721600	985	995	expression	T045	C1171362
27721600	1014	1043	cytoplasm of epithelial cells	T026	C2325751
27721600	1049	1072	SHH signaling component	T044	C3158055
27721600	1096	1108	pathological	T169	C1521733
27721600	1109	1118	parameter	T081	C0392762
27721600	1122	1126	OSCC	UnknownType	C0747035
27721600	1131	1135	oral	T030	C0226896
27721600	1136	1156	epithelial dysplasia	T191	C0878500